Is Alveolar Histotype a Prognostic Factor in Paratesticular Rhabdomyosarcoma? The Experience of Italian and German Soft Tissue Sarcoma Cooperative Group

Pediatric Blood and Cancer

Volumn 42, Issue 2, 2004, Pages 134-138

  Ferrari, Andrea ^a   Bisogno, G ^b   Casanova, M ^a   Brecht, I B ^c   Alaggio, R ^b   Cecchetto, G ^b   Provenzi, M ^d   Koscielniak, E ^c   Treuner, J ^c   Carli, M ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Olga Hospital   (Italy)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

Alveolar rhabdomyosarcoma; Paratesticular rhabdomyosarcoma; Prognostic factors; Treatment

Indexed keywords

ALKYLATING AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; COOPERATION; EMBRYONAL CARCINOMA; FOLLOW UP; GERMANY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ITALY; LUNG ALVEOLUS; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; TESTIS CANCER; TISSUE TYPES; TREATMENT OUTCOME;

EID: 10744219537     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.10460     Document Type: Article

References (19)

1. Wexler LH, Crist WH, Helman LJ. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo PA, Poplack DC, editors. Principles and practice of pediatric oncology, 4th edition. Philadelphia, PA: Lippincott-Raven; 2002. pp 939-971.
2. Ferrari A, Bisogno G, Casanova M, et al. Paratesticular rhabdomyosarcoma: Report from the Italian and German Cooperative Group. J Clin Oncol 2002;20:449-455.
3. Stewart RJ, Martelli H, Oberlin O, et al. Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: Results of the malignant mesenchymal tumors studies (MMT84 and MMT 89) of the International Society of Pediatric Oncology. J Clin Oncol 2003;21:793-798.
4. Newton WA, Soule EH, Hamoudi AB, et al. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: Clinicopathologic correlation. J Clin Oncol 1988;6:67-75.
5. Maurer HM, Beltangady M, Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study I: A final report. Cancer 1988;61:209-220.
6. Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study II. Cancer 1993;71:1904-1922.
7. Flamant F, Rodary C, Rey A, et al. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology. MMT84. Eur J Cancer 1998;34:1050-1062.
8. Koscielniak E, Harms D, Henze G, et al. Results of treatment for soft tissue sarcoma in childhood and adolescence: A final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 1999;17:3706-3719.
9. Crist WM, Anderson JR, Meza JL, et al. Intergroup Rhabdomyosarcoma Study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 2001;19:3091-3102.
10. Cecchetto G, Grotto P, De Bernardi B, et al. Paratesticular rhabdomyosarcoma in childhood: Experience of the Italian Cooperative Study. Tumori 1988;74:645-647.
11. Gamba PG, Cecchetto G, Katende M, et al. Paratesticular rhabdomyosarcoma (RMS) and paraaortic lymphadenectomy. Eur J Paed Surg 1994;4:158-160.
12. Ferrari A, Casanova M, Massimino M, et al. The management of paratesticular rhabdomyosarcoma: A single institutional experience with 44 consecutive children. J Urol 1998;159:1031-1034.
13. Newton WA, Gehan EA, Webber BL, et al. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification - An Intergroup Rhabdomyosarcoma Study. Cancer 1995;70:1073-1085.
14. Harmer MH. TNM classification of pediatric tumors. Geneva, Switzerland: UICC International Union Against cancer; 1982. pp 23-28.
15. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
16. Dall'Igna P, Bisogno G, Ferrari A, et al. Primary transcrotal excision for paratesticular rhabdomyosarcoma: Is hemiscrotectomy really mandatory. Cancer 2003;97:1981-1984.
17. Raney RB, Tefft M, Lawrence W, et al. Paratesticular sarcoma in childhood and adolescence: A report from the Intergroup Rhabdomyosarcoma studies I and II, 1973-1983. Cancer 1987;60:2337-2343.
18. Wiener ES, Lawrence W, Hays D, et al. Retroperitoneal node biopsy in paratesticular rhabdomyosarcoma. J Ped Surg 1994;29:171-178.
19. Kelly KM, Womer RB, Sorensen PH, et al. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 1997;15:1831-1836.